The findings , reported in the Journal of Urology , suggest that limiting PSA screening to men younger than 75 would prevent unnecessary testing of some men who would not benefit from treatment , according to lead researcher Dr. Karen E. Hoffman , of the University of Texas M.D. Anderson Cancer Center in Houston .